2023 Fiscal Year Annual Research Report
Effects of fish consumption on clinical response to targeted therapies in Japanese and Spanish patients with rheumatoid arthritis
Project/Area Number |
20K11597
|
Research Institution | Hokkaido University |
Principal Investigator |
Amengual Olga 北海道大学, 医学研究院, 講師 (10636939)
|
Co-Investigator(Kenkyū-buntansha) |
渥美 達也 北海道大学, 医学研究院, 教授 (20301905)
|
Project Period (FY) |
2020-04-01 – 2024-03-31
|
Keywords | Rheumatoid arthritis / Diet / Targeted therapy / Fish consumption / n-3 PUFAs |
Outline of Annual Research Achievements |
In the fourth year, we finalized the analysis of all patients included in the retrospective study. We included 205 rheumatoid arthritis (RA) patients from the Japanese cohort and 74 patients from the Spanish cohort. Analysis showed that among Japanese RA patients receiving molecular targeted therapies, responders had a higher estimated daily intake of n-3 polyunsaturated fatty acids (n-3 PUFA) compared to non-responders. Multivariate logistic regression analysis identified intake of n-3 PUFA rich fish at least once a week as an independent factor associated with improved outcomes. In the Spanish cohort, no difference in fish consumption was observed between responders and non-responders to molecular targeted therapies. We have finalized the manuscript and are preparing to send it to an international journal shortly after incorporating feedback and receiving approval from all co-authors. We launched the prospective study phase, recruited a total of 50 RA patients who initiated a new targeted therapy and completed dietary assessments. Thirty-two patients completed the second visit after a 3-month follow-up to assess their response to treatment. Data from these visits have been collected and incorporated into the database. However, given the design of the study, the analysis will be completed at the conclusion of the data collection for the two visits of all patients.
|
-
-
-
[Presentation] Fish consumption influences treatment response in patients with rheumatoid arthritis on molecular targeted therapy2024
Author(s)
Tarumi M, Amengual O, Yasuda M, Kosumi Y, Takeyama S, Hisada R, Kono M, Fujieda Y, Kato M, Atsumi T
Organizer
第68回日本リウマチ学会総会・学術集会. International Concurrent Workshop.2024年4月18~ 20日,神戸
-
-
[Presentation] Relationship between fish consumption and response to treatment with molecular targeted therapies in patients with rheumatoid arthritis.2023
Author(s)
Tarumi M, Amengual O, Navidad Fuentes M, Yasuda M, Kosumi Y, Takeyama S, Yoshimura M, Ninagawa K , Aso K, Hisada R, Kono M, Fujieda Y, Kato M, Caliz R, Atsumi T
Organizer
The Annual European Congress of Rheumatology (EULAR). Milan, Italy, 31 May-3 June
Int'l Joint Research
-
[Presentation] An endogenous metabolite, itaconate ameliorates collagen-induced arthritis by inhibiting fibroblast-like synoviocytes proliferation and migration2023
Author(s)
Tada M, Kudo Y, Kono M, Sakiyama K, Takeyama S, Hisada R, Fujieda Y, Kato M, Amengual O, Atsumi T
Organizer
The Annual Meeting of the Federation of Clinical Immunology Societies, Boston, USA, 20 Jun, 2023
Int'l Joint Research
-
-